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The 6th International Meeting on Bone Marrow Adiposity (BMA) entitled “Marrow
Adiposity: Bone, Aging, and Beyond” (BMA2020) was held virtually on September 9th
and 10th, 2020. The mission of this meeting was to facilitate communication and
collaboration among scientists from around the world who are interested in different
aspects of bone marrow adiposity in health and disease. The BMA2020 meeting brought
together 198 attendees from diverse research and clinical backgrounds spanning fields
including bone biology, endocrinology, stem cell biology, metabolism, oncology, aging,
and hematopoiesis. The congress featured an invited keynote address by Ormond
MacDougald and ten invited speakers, in addition to 20 short talks, 35 posters, and
several training and networking sessions. This report summarizes and highlights the
scientific content of the meeting and the progress of the working groups of the BMA
society (http://bma-society.org/).
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INTRODUCTION
The primary goal of the 6th international meeting on Bone Marrow Adiposity, “Marrow Adiposity:
Bone, Aging, and Beyond” (BMA2020), was to provide a forum for basic, translational, and clinical
scientists from around the world to discuss different aspects of bone marrow adiposity in health and
disease. The Bone Marrow Adiposity Society (BMAS) conferences are greatly enhanced by the
broad research and training backgrounds among conference organizers, speakers, and attendees
that promote diverse perspectives and opportunities for collaboration. The field of bone marrow
adipose tissue (BMAT) research is growing, which was reflected in the BMA2020 program. Besides a
specific focus on aging and osteoporosis, the BMA2020 meeting program included sessions related
to the role of BMAT in hematopoiesis, regulation of systemic energy metabolism, cancer
development and metastasis, and response to environmental cues including nutrition and
exercise (See Figure 1).
The BMA2020 meeting was hosted in partnership with the American Society for Bone and
Mineral Research (ASBMR) and was co-organized by Drs. Erica Scheller (Washington University),
Meghan McGee-Lawrence (Augusta University), and Beata Lecka-Czernik (The University of
Toledo). BMA2020 was originally scheduled to take place in Seattle, Washington as the first BMA
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meeting in the United States. However, due to the global
COVID-19 pandemic, the congress was instead hosted entirely
online in a mixed live/asynchronous format to promote both
networking and accessibility. With great thanks to the dedication
of our BMAS members, both established and new, this meeting
ended up being our largest event to date with 11 invited speakers,
55 submitted abstracts, and 198 registered attendees from 18
different countries around the world. The congress featured 53
sessions and sub-sessions, 35 posters, and 14 lab highlights that
were viewed collectively more than 7,000 times. In direct
evidence of the collaborative nature of the meeting, there were
also 63 photos shared and 1,391 in-app messages sent between
colleagues. In all, despite the change in format, the BMA2020
meeting succeeded in bringing together clinicians and scientists
studying all aspects of bone marrow adiposity, contributing to
the advancement of the field.
SCIENTIFIC SESSIONS
The scientific sessions at BMA2020 included bone marrow
adipocyte (BMAd) dynamics and bone mass in aging, obesity
and malnutrition, as well as BMAd progenitors and lineage
tracing, metabolism, hematopoiesis, metastasis, leukemia and
myeloma, endocrine regulation, exercise, and advanced methods
of BMAd imaging and analysis, as discussed below. A full list of
talks and speakers is available in Supplemental Table 1. Where
available, references to recently published related manuscripts
are provided below.
Keynote Address
BMA2020 opened with a welcome address from the conference
organizers, followed immediately by a keynote presentation by
Ormond MacDougald (University of Michigan) entitled “Bone
marrow adipose tissue biology, endocrine physiology and
metabolism – unique and common traits with peripheral
adipose tissue depots”. In his talk, Dr. MacDougald highlighted
the basis of BMAd cell biology and physiology as grounded in the
broader field of adipose tissue biology. He went on to discuss the
nature of regulated and constitutive BMAT clusters (rBMAT and
cBMAT, respectively), the discovery of which ultimately
provided bases for in-depth analysis of the unique metabolic
regulation of BMAT relative to other fat depots in the body (1).
Thus, rBMAT located in proximal skeletal elements and closer to
FIGURE 1 | Bone marrow adipose tissue (BMAT) – friend or foe? In health, BMAT supports physiological homeostasis. In pathological states, BMAT augments
dysregulation of physiological homeostasis. The diagram depicts the emerging topics within the field of BMAT research.
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body core temperature is interspersed with hematopoietic,
stromal and vascular cells and changes its volume in response to
hormonal, nutritional and pharmacological challenges. In contrast,
cBMAT, which is located distally and relatively further from the
body core temperature, shares similar characteristics with white
adipose tissue and is largely resistant to environmental stimuli (2).
However, cBMAT volume in humans may change after bariatric
surgery and in certain hematologic conditions (3). Dr. MacDougald
also introduced the first animal model that specifically targets
marrow adipocytes by expressing both adipocyte-targeted
(adiponectin) and osteoblast-targeted (osterix) markers, a
combination that is characteristic for BMAds. This conditional
model may ultimately help the field to understand BMAT function
in diverse settings of bone loss, as well as its contributions to
systemic energy metabolism. In summary, this keynote
presentation was a perfect introduction to the entire conference
by highlighting the unique position of BMAT among other fat
depots, which may explain its divergent functions in health and
disease as explored in the subsequent sessions.
Session I: Bone Marrow Adipose Tissue,
Aging, and Skeletal Homeostasis
The first session featured an invited talk by Sundeep Khosla
(Mayo Clinic) that covered aspects of BMAT, aging, senolytics
and skeletal health. A key focus of his presentation was that
cellular senescence may play a causal role in reducing
osteoblastogenesis and increasing adipogenesis during the
process of aging, suggesting that senolytic drugs have potential
to target this aspect of skeletal aging biology (4). The invited talk
was followed by four short talks from Anuj Sharma (Augusta
University), Abhishek Chandra (Mayo Clinic), Thomas Ambrosi
(Stanford University), and Vagelis Rinotas (Agricultural
University of Athens) that covered topics including sex
differences in marrow adiposity induced by glucocorticoid
signaling, radiation-associated bone marrow adiposity, skeletal
stem cell diversity, and the role of RANKL in development of
BMAd expansion and osteoporosis. The session was moderated
by Bram van der Eerden (Erasmus University Rotterdam) and
Rosella Labella (Columbia University). The presentation content,
and subsequent discussion, focused heavily on mechanisms of
cross-talk between cells, and the influence of the bone marrow
niche environment (particularly with aging) on mechanisms of
increasing marrow adiposity. The first short talk highlighted the
sexually dimorphic low bone mass and high BMAT phenotype of
mice with conditional deletion of the glucocorticoid receptor in
osteoprogenitor cells (5). The second talk demonstrated the time
course of molecular events leading to enhanced marrow adiposity
following irradiation of bone, and highlighted similarities in
mechanisms of senescence between aging and irradiated bone
that precede fatty infiltration of the bone marrow cavity (6). In
the third talk, single cell RNA-sequencing was used to show
alterations in the skeletal stem cell populations that promote a
pro-inflammatory, pro-resorptive, pro-adipogenic, and anti-
osteogenic environment within the bone marrow niche that could
be pharmacologically targeted (7). The fourth and final short talk
characterized marrow adiposity and BMSC differentiation patterns
in two different RANKL transgenic mouse models and explored the
molecular mechanisms underlying the observed phenotypes (8).
Session II: Environmental Regulation of
Bone and Marrow Adipose Tissue
The second session included two invited talks by Pouneh Fazeli
(University of Pittsburgh) and Janet Rubin (University of
North Carolina), followed by a short talk from Piotr Czernik
(The University of Toledo). It was moderated by Anne Schafer
(University of California San Francisco) and Rebecca Schill
(University of Michigan). The session was concentrated on
regulators of BMAT volume including nutrition, exercise and
gut microbiota. Dr. Fazeli reviewed research focused on the
paradox of increased BMAT volume in anorexia nervosa, a
clinical condition of chronic undernutrition, with a take home
message that BMAT serves different functions in states of
nutrient sufficiency as compared to nutrient insufficiency (9).
In addition, she emphasized the important function of BMAT in
regulation of hematopoiesis by demonstrating that BMAT is
inversely associated with white and red blood cell counts in
premenopausal women, and by showing that in women with
anorexia treated with transdermal estrogen, decreases in BMAT
were significantly associated with increases in both red blood
cells and hematocrit (10). Dr. Rubin focused her presentation on
the effect of exercise on adaptive changes in bone, including
decreases in BMAT volume and increases in osteogenesis. This
presentation added new information to the ongoing discussion
on sequestration of b-catenin and Wnt pathway activity in
regards to the BMSC lineage commitment and identified EZH2
as key to preservation of BMSC multipotentiality via b‐catenin
(11, 12). To conclude the session, a short talk by Piotr Czernik
revealed that reconstitution of the gut microbiome in germ-free
rats increased marrow adipocyte number and altered their cell
size distribution toward smaller adipocytes. His work suggests
that gut microbiota deliver powerful signals to the skeleton to
regulate bone marrow adipocyte differentiation and function and
that de novo expansion of small adipocytes synergizes with new
bone formation in conditions of acute nutrient utilization in the
gut (13).
Session III: Endocrine Regulation of
Bone Marrow Adipose Tissue in Health
and Disease
Session III began with an invited talk by Clifford Rosen (Maine
Medical Center Research Institute). This presentation focused on
the role of hormones, especially parathyroid hormone, in the
regulation of BMAT viamechanisms such as lineage recruitment
and lipolysis (14, 15). The invited talk was followed by three
short talks by Nikki Aaron (Columbia University), Sudipta Baroi
(The University of Toledo), and Li Chen (Southern Denmark
University) that covered topics including novel adipokines,
osteocytic control of marrow adiposity via sclerostin production,
and crosstalk between the immune system and bone. This session
was moderated by Laura McCabe (Michigan State University) and
Biagio Palmisano (Columbia University). The first short talk
reported the role of the novel adipokine adipsin and its ability
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to activate the immune complement system in BMAT expansion
promoted by caloric restriction or thiazolidinedione treatment
(16). The second short talk described the role of PPARg in
osteocytes, showing that the sclerostin gene is regulated by
PPARg and that osteocyte-specific conditional knockout mice
have a high bone mass and low BMAT phenotype (17). The
third and final short talk in this session examined the regulatory
role of the immune system complement factor H in bone and
BMAT homeostasis (18).
Session IV: Advanced Methods for Clinical
and Pre-Clinical Assessment of Bone
Marrow Adiposity and Skeletal Health
This methods-focused session started with two invited speakers,
Gustavo Duque (University of Melbourne) and Greet Kerckhofs
(Université Catholique de Louvain), followed by two short talks
from Kisoo Pahk (Korea University AnamHospital) and Josefine
Tratwal (Ecole Polytechnique Fédérale de Lausanne). Session IV
was moderated by Jean-Francois Budzik (Groupement des
Hôpitaux de l’Institut Catholique de Lille) and Ahmed Al
Saedi (University of Melbourne). Dr. Duque discussed secreted
factors that couple bone marrow adipocytes to the surrounding
skeletal cells and their implications for the pathophysiology of
osteoporosis. In addition, he provided information about key
technical approaches that can be used to study aspects of bone
marrow adipocyte function and lipotoxicity both in vitro and ex
vivo (19, 20). After this, Dr. Kerckhofs demonstrated how novel
contrast agents such as polyoxometalate can be used to visualize
and to quantify bone marrow adipocytes in three dimensions, in
addition to relating this information to bone and vascular
quantifications using high-resolution computed tomography
(21). Next, Kisoo Pahk reported the use of 18F-FDG PET/CT
for the evaluation of adipose tissue metabolic activity in patients
with osteoporosis, demonstrating that metabolic activity of
visceral vs subcutaneous adipose tissue is predictive of bone
mineral density (22). Last, Josefine Tratwal gave an overview of a
new injectable, three-dimensional tissue engineered model of
bone marrow adipogenesis and hematopoiesis that can be used
to accelerate studies on the regeneration of the bone marrow
niche for treatment of blood and other marrow-related
disorders (23).
Session V: Bone Marrow Adipose Tissue,
Cancer, and Hematopoiesis
The invited speakers for Session V were Olaia Naiveras (École
Polytechnique Fédérale de Lausanne) and Izabela Podgorski
(Wayne State University). Short talks were given by Emma
Morris (University of Oxford), Sonia Severin (Inserm U1048
and Paul Sabatier University), and Mariah Farrell (Maine
Medical Center Research Institute). The session was moderated
by Michaela Reagan (Maine Medical Center Research Institute)
and Josefine Tratwal (Ecole Polytechnique Fédérale de
Lausanne). Session V focused on mechanisms by which BMAT
regulates hematopoiesis and cancer progression. Olaia Naveiras
summarized the effects of BMAT on hematopoiesis, including
use of MarrowQuant, a new tool for quantification of bone
marrow compartments in histologic sections (24). This
presentation concluded that marrow adiposity correlates
inversely with hematopoiesis in health and pathologic
conditions, and that the degree of adipocyte maturation
correlates inversely with the proliferation of hematopoietic
precursors. In addition, Dr. Naiveras identified loss of SCF
upon differentiation of BMAT progenitor cells as responsible
for decreased support of hematopoiesis (25). After this, Izabela
Podgorski showed that BMAT fuels and supports growth of
prostate cancer metastasis to bone by serving as an abundant
source of lipids and signaling molecules. She demonstrated
that metastatic tumor cells engage in reciprocal interactions
with bone marrow adipocytes to evade therapy and provided
evidence that targeting IL-1b or lipolysis improves tumor
cell response to anti-cancer therapy with docetaxel (26).
Dr. Podgorski concluded her talk by stressing an importance
of understanding the role of BMAT in tumor adaptation
and survival in bone, as a tool to reveal novel, mechanistic
targets for therapies for prostate and breast bone-metastatic
diseases, which continue to be incurable (27). After this, Emma
Morris discussed the effects of PPARg agonist BAGDE on
myeloma cells and bone marrow adipocytes (28), Sonia Severin
showed a functional link between marrow adipocytes and the
development of megakaryocytes (29), and Mariah Farrell
revealed that bone marrow adipocytes support multiple
myeloma drug resistance and induce adipocyte mimicry,
increasing cell survival (30, 31). Overall, this session stressed
an importance of understanding the role of BMAT in
hematopoiesis and cancer cell survival in bone, while
underscoring a prominent role of adipocytes in the regulation
of different components of hematopoietic niche.
Session VI: Bone Marrow Adipose Tissue
Origins and Maturation
This session featured an invited talk by Moustapha Kassem
(University of Southern Denmark) and three short talks by Russell
Turner (Oregon State University), Leilei Zhong (University of
Pennsylvania), and Xiao Zhang (Washington University). Session
VI was moderated by Michaela Tencerova (University of Southern
Denmark) and Sudipta Baroi (The University of Toledo). Dr.
Kassem opened the session by reviewing the mechanisms
underlying lineage commitment of multipotent bone marrow
stromal (skeletal) stem cells to adipocytes with an emphasis on the
role of KIAA1199 (32). Next, Dr. Turner presented data showing
that c-kit expression in hematopoietic and mesenchymal cells
contributes to the maturation of bone marrow adipocytes (33).
After this, Leilei Zhong presented new data that defines a stromal/
perivascular, adiponectin-expressing bone marrow adipocyte
progenitor, termed the marrow adipogenic lineage precursor
(MALP) and its role in the maintenance of the bone marrow
vasculature (34, 35). Last, Xiao Zhang showed that a unique
population of maladapted bone marrow adipocytes was retained in
an otherwise ‘fat free’ lipodystrophic mouse, revealing the existence
of a bone-specific, compensatory adipogenesis pathway that is
activated in states of metabolic stress (36). Overall, this session
contributed to our understanding of the unique cellular origins of
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bone marrow adipocytes during development and metabolic disease,
in addition to providing new information about the molecular
signals regulating the maturation of committed pre-adipocytes
within the bone marrow.
Session VII: Bone Marrow Adipocyte
Differentiation, Metabolism and the
Skeletal Niche
The final session started with an invited talk by Courtney Karner
(University of Texas Southwestern Medical Center), followed by
four short talks by Ziru Li (University of Michigan), Ayyoub
Salmi (MABlab), Amit Chougule (University of Toledo), and
Wei Yu (University of Pennsylvania). The session was
moderated by Christophe Chauveau (MABLab) and Thomas
Ambrosi (Stanford University). Dr. Karner presented on the role
of glutamine metabolism in the fate specification of bone marrow
adipocytes from mesenchymal precursor cells, providing support
for a model by which inhibition of glutamine metabolism or
glutathione biosynthesis increases oxidative stress and promotes
adipocyte differentiation (37). After this, Dr. Li presented work
in a conditional adipose triglyceride lipase knockout mouse
demonstrating roles for bone marrow adipocyte lipolysis in
states of nutrient deficiency. Next, Ayyoub Salmi presented
evidence in support of the capacity for osteoblasts to
transdifferentiate to adipocyte-like cells following co-culture
with adipocytes, emphasizing the plasticity and intercellular
communication of cell populations within bone (38). This was
followed by a presentation from Amit Chougule showing that
activation of PPARa in the osteocyte lineage suppresses bone
marrow adipose tissue expansion in regions of hematopoietic
marrow. Last, Wei Yu demonstrated that adiponectin-expressing
MALP cells are a critical source of osteoclast-regulatory factor
RANKL, contributing directly to osteoclast formation and bone
turnover (35). The questions and discussion in this diverse
session centered on Cre specificity and the use of Cre-
dependent lineage tracing when compared to surface marker
strategies for characterization of bone marrow adipocyte
progenitors. In addition, the group emphasized the need to
continue to work together to unify our models and definitions
to promote the advancement of future work in the field.
POSTERS
Posters consisted of a pre-recorded video presentation of up to 5-
minutes in length. Virtual posters were highlighted in the
exhibitor center and could be viewed asynchronously by
congress attendees. A live poster session was also held on the
first day of the conference where attendees and presenters could
post and respond to questions in real time. The highlighted
topics of the posters fell into several main categories including
aging, BMAT dynamics and bone mass, endocrine regulation,
imaging and advanced methods, metabolism, metastasis,
myeloma and hematopoiesis, obesity and malnutrition, and
progenitors and lineage tracing. A detailed list of posters and
presenters is available in Supplemental Table 2.
NETWORKING AND PROFESSIONAL
DEVELOPMENT
The Bone Marrow Adiposity Society is committed to fostering
collaborations between members and to the development of
trainees and fellows to support the growth and advancement of
the field. Consistent with this mission, the BMA2020 meeting
featured several trainee discussion sessions and networking
events. All members were invited to participate in an open
discussion with keynote speaker Dr. Ormond MacDougald, a
question-and-answer session with leaders from the National
Institutes of Health, and a BMA2020 ‘After Hours Trivia’
social event hosted by Don’t Tell Comedy. In addition, there
were two trainee-specific sessions focused on topics including
publishing, preprints, and open access (led by William
Cawthorn, The University of Edinburgh) and planning for life
and job opportunities after research training (led by Gina
Woods, UCSD, Hai-Bin Ruan, University of Minnesota, and
Christa Maes, KU Leuven). The meeting organizers would like to
provide special thanks to Andrea Lovdel and Biagio Palmisano
for their contributions to the development of the trainee-focused
content and trivia event of the BMA2020 meeting.
BMAS WORKING GROUPS
In addition to networking and scientific content, the BMA2020
symposium provided a forum for meetings of the six BMAS
working groups (WG). Additional information on the activities
of the working groups can also be obtained by following BMAS
on twitter (@BMA_Society).
WG1 – Nomenclature. The nomenclature working group
position paper reporting Standardized Nomenclature, Abbreviations,
and Units for the Study of Bone Marrow Adiposity was published in
2020 (39). The current goal ofWG1 is to promote the awareness and
application of these guidelines among researchers, journal editors
and publishers, and to continue monitoring the emergence of new
terms and methods to ensure that the guidelines are updated as the
field continues to develop.
WG2 – Methodologies. The goal of the methodologies
working group is to encourage the use of standardized
methodologies for the assessment of bone marrow adipocytes.
The methodologies working group recently published a review on
standardization in methodology for the study of bone marrow
adiposity (40). After welcoming new members, the methodologies
working group decided on new projects. In the coming years the
group will focus on in-depth review and discussion of in vivo
imaging methods and in vitro systems in the study of bone
marrow adiposity, leading to future publications on the topic to
promote the standard application of methods in the field.
WG3 – Biobanking. The aim of the biobanking working
group is to establish the use of standardized protocols for the
collection and storage of materials related to bone marrow
adipocytes. WG3 is currently preparing a position paper on
biobanking of BMAd-related material. This position paper will
cover several aspects of biobanking including introduction to
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biobanking with a focus on BMAd-related material, patient
information, pseudonymization and ethics, types of tissues/
sources from which BMAd-related material can be obtained, and
isolation protocols to collect bone marrow adipocytes and bone
marrow mesenchymal stromal cells for future applications. With
this, WG3 aims to reach clinicians and scientists involved in
biobanking of BMAd-related material by providing
considerations on the collection, storage and use of BMAd-samples.
WG4 - Public Engagement. The working group on public
engagement focuses on ways to educate target groups outside the
society, including other societies, patient organizations and the
public. Since the start of the working group, fruitful collaborations
have been set up with affiliating societies, such as ECTS and
ASBMR. Finally, WG4 is involved in managing the social media
(Twitter, LinkedIn) of BMAS.
WG5 – Repositories. The working group on repositories
aims to identify currently existing repositories that contain
expression data related to BMAd. Ultimately, this information
can be distributed among BMAS members to gain access to the
BMAd-related repositories for their research.
WG6 – Sponsoring. The aim of the sponsoring working
group is to find partners in industry and academia to financially
liaise with BMAS. This committee is tasked with developing a
strategy to ensure stable sponsorships for BMAS.
AWARDS
Awards were presented during the conclusion of the BMA2020
meeting for the highest scoring clinical research and basic/
translational research short talks and poster presentations. In
addition, to promote scientific discourse and interaction during
the virtual meeting, awards were also presented for the “audience
choice” best poster presentation, a social media-based photo
contest, a community engagement award, and a trivia contest.
For the abstract-based scientific awards, all abstract submissions
underwent blinded review and scoring by three to five independent
reviewers. Abstracts were categorized as “clinical research” or
“basic/translational research”, and awards were administered
proportionally to the volume of abstracts received in each
category; seven such awards were presented for basic/translational
research, and three for clinical science. For the short talk and poster
presentation awards during the meeting, presentations were scored
by representatives from the BMAS Scientific Board on the overall
presentation quality, the speaker’s responses during the question
and answer session, the impact of the data, and the overall
communication of the message. A full list of scientific awards and
recipients is provided in Supplemental Table 3.
CONCLUDING REMARKS AND
PERSPECTIVES
BMA2020 was the 6th International Meeting of the Bone Marrow
Adiposity Society. This was an important forum for discussion
within the diverse, growing field of bone marrow adiposity research.
The success of the transition to a virtual format has prompted
discussions regarding the future integration of both in-person and
virtual events to support the attendance of those that are not able to
travel to the on-site destination. Moving forward, the BMAS
meetings will be held once every 2-years with the next BMA2022
meeting currently scheduled to take place in Greece under the
direction of Eleni Douni. In addition to this, several trainees and
members within BMAS have come together to organize a virtual
training seminar entitled “BMAS Summer School 2021”. This
training seminar will take place over three half-days in September
of 2021 and feature topical lectures from international experts, skill-
based workshops, group discussions, and presentations that will
promote the career development of trainees in the field. In
conclusion, we are thankful for the overall success of the
BMA2020 symposia and the connections made between
colleagues despite the global COVID-19 pandemic. Though bone
marrow adipocytes are gaining increasing attention as an endocrine
cell and key component of the skeletal niche, much remains to be
discovered to harness their potential in anti-osteoporotic, metabolic,
cancer, hematological, or regenerative therapies. The research
highlighted at this meeting and the new collaborations formed
between colleagues will undoubtedly contribute to these efforts.
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